High-Dose Pemetrexed in Combination with High-Dose Crizotinib for the Treatment of Refractory CNS Metastases in ALK-Rearranged Non-Small-Cell Lung Cancer

被引：32
作者：
Gandhi, Leena [1 ,2 ,3 ]
Drappatz, Jan [5 ,6 ]
Ramaiya, Nikhil H. [3 ]
Otterson, Gregory A. [4 ]
机构：
[1] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02215 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02215 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[5] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[6] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷 / 01期
关键词：
D O I：
10.1097/JTO.0b013e3182762d20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E3 / E5
页数：3
相关论文
共 8 条
[1]  
Administration. UFaD, FDA LAB INF XALK
[2]   Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer [J].
Bearz, Alessandra ;
Garassino, Isabella ;
Tiseo, Marcello ;
Caffo, Orazio ;
Soto-Parra, Hector ;
Boccalon, Massimo ;
Talamini, Renato ;
Santoro, Armando ;
Bartolotti, Marco ;
Murgia, Viviana ;
Berretta, Massimiliano ;
Tirelli, Umberto .
LUNG CANCER, 2010, 68 (02) :264-268
[3]   Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed [J].
Camidge, D. Ross ;
Kono, Scott A. ;
Lu, Xian ;
Okuyama, Sonia ;
Baron, Anna E. ;
Oton, Ana B. ;
Davies, Angela M. ;
Varella-Garcia, Marileila ;
Franklin, Wilbur ;
Doebele, Robert C. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) :774-780
[4]   CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib [J].
Costa, Daniel B. ;
Kobayashi, Susumu ;
Pandya, Shuchi S. ;
Yeo, Wee-Lee ;
Shen, Zhongzhou ;
Tan, Weiwei ;
Wilner, Keith D. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E443-E445
[5]   A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer [J].
Cullen, M. H. ;
Zatloukal, P. ;
Sorenson, S. ;
Novello, S. ;
Fischer, J. R. ;
Joy, A. A. ;
Zereu, M. ;
Peterson, P. ;
Visseren-Grul, C. M. ;
Iscoe, N. .
ANNALS OF ONCOLOGY, 2008, 19 (05) :939-945
[6]   Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer [J].
Lee, Jeong-Ok ;
Kim, Tae Min ;
Lee, Se-Hoon ;
Kim, Dong-Wan ;
Kim, Soyeon ;
Jeon, Yoon-Kyung ;
Chung, Doo Hyun ;
Kim, Woo-Ho ;
Kim, Young Tae ;
Yang, Seok-Chul ;
Kim, Young Whan ;
Heo, Dae Seog ;
Bang, Yung-Jue .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) :1474-1480
[7]   Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma [J].
Raizer, Jeffrey J. ;
Rademaker, Alfred ;
Evens, Andrew M. ;
Rice, Laurie ;
Schwartz, Margaret ;
Chandler, James P. ;
Getch, Christopher C. ;
Tellez, Claudia ;
Grimm, Sean A. .
CANCER, 2012, 118 (15) :3743-3748
[8]  
Shaw AT, 2012, ANN ONCOL
1